WuXi AppTec Co Ltd H's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Net-Income-Applicable-To-Common-Shares" stands at 16.94 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 06/30/2018, the period currently displayed.
WuXi AppTec Co Ltd H's second quarter result of 8.29 Billion HKD for the item "Net Income Applicable To Common Shares" represents an increase of 134.35 percent compared to it's first quarter result.
Also, WuXi AppTec Co Ltd H's second quarter result of 8.29 Billion HKD for the item "Net Income Applicable To Common Shares" represents an increase of 235.70 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), WuXi AppTec Co Ltd H's second quarter result of 16.94 Billion HKD for the item "Net Income Applicable To Common Shares" represents an increase of 52.34 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 87.77 percent compared to the value the year prior.
The 1 year change in percent is 87.77.
The 3 year change in percent is 99.51.
The 5 year change in percent is 555.59.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Income Applicable To Common Shares | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Income Applicable To Common Shares | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Income Applicable To Common Shares | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Income Applicable To Common Shares | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Income Applicable To Common Shares | 280,205,508,085.11 |